NO304427B1 - Piperidinester og medikament og farmas°ytisk preparat omfattende denne - Google Patents
Piperidinester og medikament og farmas°ytisk preparat omfattende denneInfo
- Publication number
- NO304427B1 NO304427B1 NO952761A NO952761A NO304427B1 NO 304427 B1 NO304427 B1 NO 304427B1 NO 952761 A NO952761 A NO 952761A NO 952761 A NO952761 A NO 952761A NO 304427 B1 NO304427 B1 NO 304427B1
- Authority
- NO
- Norway
- Prior art keywords
- drug
- pharmaceutical preparation
- piperidine ester
- piperidine
- ester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9408711A FR2722497B1 (fr) | 1994-07-13 | 1994-07-13 | Esters de alpha-4-chlorophenyl)-4-(4-fluorophenyl)methyl) piperidine-1-ethanol, leur preparation et leur application en therapeutique |
Publications (3)
Publication Number | Publication Date |
---|---|
NO952761D0 NO952761D0 (no) | 1995-07-12 |
NO952761L NO952761L (no) | 1996-01-15 |
NO304427B1 true NO304427B1 (no) | 1998-12-14 |
Family
ID=9465359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952761A NO304427B1 (no) | 1994-07-13 | 1995-07-12 | Piperidinester og medikament og farmas°ytisk preparat omfattende denne |
Country Status (19)
Country | Link |
---|---|
US (1) | US5620990A (no) |
EP (1) | EP0692472A1 (no) |
JP (1) | JPH0859616A (no) |
KR (1) | KR960004322A (no) |
CN (1) | CN1120038A (no) |
AU (1) | AU695312B2 (no) |
CA (1) | CA2153726A1 (no) |
CZ (1) | CZ180795A3 (no) |
FI (1) | FI953410A (no) |
FR (1) | FR2722497B1 (no) |
HU (1) | HU215599B (no) |
IL (1) | IL114562A (no) |
NO (1) | NO304427B1 (no) |
NZ (1) | NZ272552A (no) |
PL (1) | PL309589A1 (no) |
RU (1) | RU95113144A (no) |
SK (1) | SK88795A3 (no) |
TW (1) | TW374084B (no) |
ZA (1) | ZA955801B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9701282A (es) * | 1994-08-18 | 1997-05-31 | Pfizer | Fenoles neuroprotectores. |
AU9646298A (en) * | 1997-10-27 | 1999-05-17 | Sumitomo Pharmaceuticals Company, Limited | Amide derivatives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
FR2628740B3 (fr) * | 1989-04-12 | 1990-01-19 | Synthelabo | Procede de preparation des enantiomeres du (chloro-4 phenyl)-1 (((fluoro-4 phenyl)methyl)-4 piperidyl-1)-2 ethanol |
ES2060547B1 (es) * | 1992-06-04 | 1995-06-16 | Ferrer Int | Mejoras en el objeto de la patente de invencion n/ 9201158 que se refiere a "procedimiento de obtencion de nuevos derivados de la 4-bencilpiperidina". |
FR2694555A1 (fr) * | 1992-08-05 | 1994-02-11 | Synthelabo | Procédé de péparation des énantiomères du 1-(4-chloro-2-hydroxyphényl)-2-[4-[(4-fluorophényl)méthyl]-piperidin-1-yl]éthanol. |
US5434171A (en) * | 1993-12-08 | 1995-07-18 | Eli Lilly And Company | Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
-
1994
- 1994-07-13 FR FR9408711A patent/FR2722497B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-05 TW TW084106936A patent/TW374084B/zh active
- 1995-07-10 EP EP95401658A patent/EP0692472A1/fr not_active Withdrawn
- 1995-07-11 US US08/499,918 patent/US5620990A/en not_active Expired - Fee Related
- 1995-07-12 FI FI953410A patent/FI953410A/fi unknown
- 1995-07-12 AU AU24922/95A patent/AU695312B2/en not_active Ceased
- 1995-07-12 NO NO952761A patent/NO304427B1/no not_active IP Right Cessation
- 1995-07-12 CA CA002153726A patent/CA2153726A1/en not_active Abandoned
- 1995-07-12 HU HU9502113A patent/HU215599B/hu not_active IP Right Cessation
- 1995-07-12 IL IL11456295A patent/IL114562A/xx active IP Right Grant
- 1995-07-12 JP JP7176013A patent/JPH0859616A/ja active Pending
- 1995-07-12 SK SK887-95A patent/SK88795A3/sk unknown
- 1995-07-12 ZA ZA955801A patent/ZA955801B/xx unknown
- 1995-07-12 RU RU95113144/04A patent/RU95113144A/ru unknown
- 1995-07-12 CN CN95108920A patent/CN1120038A/zh active Pending
- 1995-07-12 PL PL95309589A patent/PL309589A1/xx unknown
- 1995-07-12 KR KR1019950020426A patent/KR960004322A/ko not_active Application Discontinuation
- 1995-07-12 NZ NZ272552A patent/NZ272552A/en unknown
- 1995-07-12 CZ CZ951807A patent/CZ180795A3/cs unknown
Also Published As
Publication number | Publication date |
---|---|
AU695312B2 (en) | 1998-08-13 |
PL309589A1 (en) | 1996-01-22 |
TW374084B (en) | 1999-11-11 |
FR2722497A1 (fr) | 1996-01-19 |
RU95113144A (ru) | 1997-06-27 |
NZ272552A (en) | 1996-06-25 |
CN1120038A (zh) | 1996-04-10 |
IL114562A0 (en) | 1995-11-27 |
NO952761L (no) | 1996-01-15 |
HU9502113D0 (en) | 1995-09-28 |
SK88795A3 (en) | 1996-02-07 |
KR960004322A (ko) | 1996-02-23 |
FR2722497B1 (fr) | 1996-08-14 |
IL114562A (en) | 1999-11-30 |
ZA955801B (en) | 1996-04-25 |
HUT73137A (en) | 1996-06-28 |
CA2153726A1 (en) | 1996-01-14 |
NO952761D0 (no) | 1995-07-12 |
FI953410A (fi) | 1996-01-14 |
HU215599B (hu) | 1999-01-28 |
JPH0859616A (ja) | 1996-03-05 |
EP0692472A1 (fr) | 1996-01-17 |
CZ180795A3 (en) | 1996-01-17 |
US5620990A (en) | 1997-04-15 |
FI953410A0 (fi) | 1995-07-12 |
AU2492295A (en) | 1996-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000932D0 (no) | Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant | |
NO943888D0 (no) | Farmasöytisk preparat | |
NO924768D0 (no) | Farmasoeytisk preparat og fremgangsmaate for dets fremstilling | |
NO973612D0 (no) | Nytt farmasöytisk preparat | |
IS5245A (is) | Lyfjablanda úr ómeprasól | |
IS4644A (is) | Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra | |
NO953874D0 (no) | Farmasöytisk preparat inneholdende lipofile legemidler | |
NO922506D0 (no) | Farmasoeytiske preparat | |
NO962694D0 (no) | Percutant farmasöytisk preparat | |
BR9500784A (pt) | Composto e formulação farmacêutica | |
BR9504060A (pt) | Composto e formulação farmacêutica | |
NO921958D0 (no) | Farmasoeytisk preparat | |
NO922006L (no) | Farmasoeytisk preparat | |
DE69525148D1 (de) | Pharmazeutische formulierung | |
IS5070A (is) | Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það | |
NO961274D0 (no) | Azolderivat og farmasöytiske preparat derav | |
ID22053A (id) | Turunan asam aminofosfonat dalam sediaan farmasi | |
NO993731L (no) | Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne | |
NO934372D0 (no) | Nye forbindelser og farmas!ytisk preparat derav | |
NO180678C (no) | N-substituerte heterocykliske forbindelser og farmasöytisk preparat | |
NO20006576L (no) | Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette | |
NO990335D0 (no) | Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling | |
NO973610D0 (no) | Nytt farmasöytisk preparat | |
NO973980D0 (no) | Imiadazolderivater og medisinsk preparat | |
NO973611D0 (no) | Nytt farmasöytisk preparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JANUARY 2001 |